Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Hosted on MSN19d
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries(Reuters) - Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make ...
Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...
The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...
In response to increased criticism of its pricing, Gilead Sciences has reached voluntary licensing deals with companies to make generic versions of its twice-yearly HIV medicine, lenacapavir ...
The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...
“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...
Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...
Here are some regions that are attracting biotech and pharma companies.
Despite major advances in scientific innovation, access to care and growth of health systems, there are still millions of ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback